A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)-Reference-Cited by-同舟云学术

A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

Published:2022-10 Issue:5 Volume:20 Page:404-414
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Kreiberg Michael^ORCID,Jørgensen Niels,Juul Anders,Lauritsen Jakob,Oturai Peter,Helge Jørn Wulff,Christensen Jesper Frank,Aksglaede Lise,Schauer Tim,Wagner Thomas,Rosenvilde Josephine,Grunwald Emma,Dehlendorff Christian,Daugaard Gedske,Bandak Mikkel

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference35 articles.

1. Global Cancer Observatory: Cancer Today;Ferlay,2022

2. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium;Gillessen;J Clin Oncol,2021

3. Late relapses in stage I testicular cancer patients on surveillance;Saksø;Eur Urol,2017

4. Surveillance for stage I nonseminoma testicular cancer: Outcomes and long-term follow-up in a population-based cohort;Daugaard;J Clin Oncol,2014

5. Cardiovascular risk factors and disease after male germ cell cancer;Lauritsen;J Clin Oncol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency;Clinical Genitourinary Cancer;2023-08

2. Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment;Current Oncology Reports;2023-03-03

3. Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial;Clinical Genitourinary Cancer;2022-08